These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 9035375

  • 1. Synthesis and cholinesterase inhibitory activity of 6-, 7-methoxy-(and hydroxy-) tacrine derivatives.
    Del Giudice MR, Borioni A, Mustazza C, Gatta F, Meneguz A, Volpe MT.
    Farmaco; 1996 Nov; 51(11):693-8. PubMed ID: 9035375
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K.
    Bioorg Med Chem Lett; 2010 Oct 15; 20(20):6093-5. PubMed ID: 20817518
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
    Elsinghorst PW, Tanarro CM, Gütschow M.
    J Med Chem; 2006 Dec 14; 49(25):7540-4. PubMed ID: 17149883
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of huperzine B on cholinesterase activity in mice.
    Liu J, Zhang HY, Wang LM, Tang XC.
    Zhongguo Yao Li Xue Bao; 1999 Feb 14; 20(2):141-5. PubMed ID: 10437161
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases.
    Wang Y, Guan XL, Wu PF, Wang CM, Cao H, Li L, Guo XJ, Wang F, Xie N, Jiang FC, Chen JG.
    J Med Chem; 2012 Apr 12; 55(7):3588-92. PubMed ID: 22420827
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.
    Fang L, Appenroth D, Decker M, Kiehntopf M, Roegler C, Deufel T, Fleck C, Peng S, Zhang Y, Lehmann J.
    J Med Chem; 2008 Feb 28; 51(4):713-6. PubMed ID: 18232655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of tacrine-lophine hybrids via one-pot four component reaction and biological evaluation as acetyl- and butyrylcholinesterase inhibitors.
    da Costa JS, Lopes JP, Russowsky D, Petzhold CL, Borges AC, Ceschi MA, Konrath E, Batassini C, Lunardi PS, Gonçalves CA.
    Eur J Med Chem; 2013 Apr 28; 62():556-63. PubMed ID: 23422935
    [Abstract] [Full Text] [Related]

  • 15. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI, Pérez C, Monjas L, Rademann J, Rodríguez-Franco MI.
    J Med Chem; 2012 Feb 09; 55(3):1303-17. PubMed ID: 22243648
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and molecular-modeling study of aminothienopyridine analogues of tacrine for Alzheimer's disease.
    Badran MM, Abdel Hakeem M, Abuel-Maaty SM, El-Malah A, Abdel Salam RM.
    Arch Pharm (Weinheim); 2010 Oct 09; 343(10):590-601. PubMed ID: 20925094
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.